Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters
Ms. Miller et al., Differential sensitivity to lung tumorigenesis following transplacental exposure of mice to polycyclic hydrocarbons, heterocyclic amines, and lung tumor promoters, EXP LUNG R, 26(8), 2000, pp. 709-730
Research conducted bg this laboratory over the past decade has demonstrated
the high susceptibility of the fetus to lung tumor formation following in
utero exposure of the resistant C57BL/6 and DBA/2N strains of mice to 3-met
hylcholanthrene (MC). In this review, we describe our more recent studies o
n the effects of MC and cotreatment with the lung tumor promoter, butylated
hydroxytoluene (BHT), on lung tumor formation in the intermediately suscep
tible BALB/c strain of mice, and the determination of the potential carcino
genicity of the heterocyclic amine, 2-amino-methylimidazo[4,5-f]quinoline (
IQ) in resistant mouse strains. BALB/c mice showed a similar incidence of l
ung tumors, both in terms of percentage of mice with tumors and number of t
umors per mouse, as found in the resistant [D2 x B6D2F1]F2 mice. Ki-ras poi
nt mutations were found in 56% (20/36) of BALB/c lung lesions compared with
an incidence of 79 % in [D2 x B6D2F1]F2 mice. BALB/c lung lesions demonstr
ated a similar association of Ki-ras mutations with tumor stage. Interestin
gly, a strain-dependent difference was observed in the mutational spectrum,
where 62 % and 38% of the lesions in BALB/c mice exhibited G--> C and G-->
T transversions, respectively, in contrast with the 16 % and 84 % incidenc
es observed in [D2 x B6D2F1]F2 mice. BHT had no statistically significant e
ffect on tumor incidence, multiplicity, or Ki-ras mutational spectrum in BA
LB/c mice treated in utero with MC, although a trend toward increased tumor
multiplicity was observed. Finally, experiments initiated to assess the tr
ansplacental carcinogenicity of IQ in D2B6F1 mice demonstrated that 1 year
after birth, no macroscopically or microscopically visible liver, lung, or
colon tumors were found in the transplacentally treated offspring nor was i
nduction of Cyp1a1, Cyp1b1, or glutathione S-transferases (GSTs) in fetal l
ung and liver tissues observed. This implies that at least under these expe
rimental conditions, IQ may not be an important transplacental carcinogen.
Overall, these data demonstrate that mutagenic damage to Ki-ras is a critic
al early event mediating murine lung tumorigenesis in both sensitive and re
sistant strains. Strain-dependent differences in the Ki-ras mutational spec
trum may be associated with their differential susceptibility to lung tumor
initiation.